[ad_1]
The world – Europe
The government said: “The government today accepted the recommendation of the Medicines and Healthcare Products Regulatory Agency (MHRA) to approve the use of the vaccine by the American company Pfizer and its German partner, Biontac.”
The vaccine will be available across the UK from next week, while Pfizer said the British emergency use permit represents a historic moment in the war against the emerging corona virus.
“This mandate is a goal we have worked toward since we first announced that science will triumph, and we salute the Medicines and Healthcare Products Regulatory Agency for its ability to carefully assess and take timely action to help protect people. from the UK, “said the CEO of the US company, Albert Burla. .
He added: “As we await more licenses and approvals, we are focusing on moving forward with the same level of urgency to safely deliver a high quality vaccine around the world.”
For his part, the British Health Minister, Matt Hancock, said that the program will start early next week, highlighting that hospitals are ready to receive it.
The Pfizer company and its partner Bayontak announced the results of the third clinical trials of the coronavirus vaccine, as the results demonstrated the effectiveness of the vaccine to protect against the epidemic.
But this vaccine needs special storage conditions, such as a temperature of minus 70 degrees, to maintain its effectiveness.
